Global Human Organs-on-Chips Competitive Landscape Professional Research Report 2025

Research Summary

Human organs-on-chips are innovative microfluidic devices designed to mimic the structure and function of human organs in a controlled laboratory setting. These microphysiological systems consist of tiny, interconnected channels lined with living human cells that replicate the architecture and physiological conditions of specific organs, such as the heart, lung, liver, or kidney. Organs-on-chips aim to provide a more accurate and dynamic representation of human biology compared to traditional cell culture or animal models. They allow researchers to study the responses of human tissues to drugs, toxins, and diseases, offering insights into organ-level functions, interactions, and potential therapeutic interventions. This technology holds promise for advancing drug development, toxicity testing, and personalized medicine, reducing the reliance on animal testing and improving the efficiency of preclinical studies in the field of biomedical research.

According to DIResearch's in-depth investigation and research, the global Human Organs-on-Chips market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Human Organs-on-Chips include Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Micronit Microtechnologies B.V., Nortis, Kirkstall, Cherry Biotech SAS, Else Kooi Laboratory, Altis Biosystems, Bi/ond, Netri, Xona Microfluidics, SynVivo, Beijing Daxiang Biotech etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Human Organs-on-Chips. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Human Organs-on-Chips market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Human Organs-on-Chips market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Organs-on-Chips industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Human Organs-on-Chips Include:

Emulate

Mimetas

TissUse

Valo Health

CN Bio Innovations

Hesperos

Draper Laboratory

Micronit Microtechnologies B.V.

Nortis

Kirkstall

Cherry Biotech SAS

Else Kooi Laboratory

Altis Biosystems

Bi/ond

Netri

Xona Microfluidics

SynVivo

Beijing Daxiang Biotech

Human Organs-on-Chips Product Segment Include:

Brain-on-a-Chip

Liver-on-a-Chip

Kidney-on-a-Chip

Lung-on-a-Chip

Heart-on-a-Chip

Intestine-on-a-Chip

Vessel-on-a-Chip

Others

Human Organs-on-Chips Product Application Include:

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Cosmetics Industry

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Human Organs-on-Chips Industry PESTEL Analysis

Chapter 3: Global Human Organs-on-Chips Industry Porter’s Five Forces Analysis

Chapter 4: Global Human Organs-on-Chips Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Human Organs-on-Chips Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Human Organs-on-Chips Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Human Organs-on-Chips Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Human Organs-on-Chips Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Human Organs-on-Chips Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Human Organs-on-Chips Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Human Organs-on-Chips Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Human Organs-on-Chips Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources